The value of preoperative neutrophil/lymphocyte ratio in predicting the severity of cholecystolithiasis with cholecystitis in elderly patients.
C-reactive protein
Diagnosis
Inflammatory biomarkers
Neutrophil-to-lymphocyte ratio
Severity of cholecystolithiasis with cholecystitis
Journal
BMC surgery
ISSN: 1471-2482
Titre abrégé: BMC Surg
Pays: England
ID NLM: 100968567
Informations de publication
Date de publication:
27 Nov 2023
27 Nov 2023
Historique:
received:
12
07
2023
accepted:
13
11
2023
medline:
29
11
2023
pubmed:
28
11
2023
entrez:
28
11
2023
Statut:
epublish
Résumé
This study aims to assess the effectiveness of neutrophil/lymphocyte ratio (NLR) and C-reactive protein (CRP) in diagnosing cholecystolithiasis with cholecystitis in elderly patients. Additionally, the study seeks to determine the predictive value of preoperative NLR in determining the severity of the condition in this population. This study is a retrospective cohort study, including 160 elderly patients with cholecystolithiasis with cholecystitis (45 cases of simple cholecystitis, 58 cases of suppurative cholecystitis, 57 cases of gangrenous cholecystitis) and 60 cases of normal gallbladder histology. The study collected clinical data of the patients detected the preoperative CRP content, neutrophil, and lymphocyte levels through blood routine tests, and calculated the NLR value. The diagnostic value of NLR and CRP was determined by using the Receiver Operating Characteristic Curve (ROC), and the optimal value of preoperative NLR related to the severity of elderly patients with cholecystolithiasis with cholecystitis was identified. This study found that for elderly patients with cholecystolithiasis with cholecystitis, preoperative NLR and CRP levels can be used to distinguish the condition. The critical value for NLR was found to be 2.995 (95% CI, 0.9465-0.9853; P < 0.001) with an area under the ROC curve of 0.9659, while the critical value for CRP was 13.05 (95% CI, 0.9284-0.9830; P < 0.001) with an area under the ROC curve of 0.9557. Both NLR and CRP were found to have equivalent diagnostic abilities. Additionally, the study found that there were significant differences in neutrophil and lymphocyte levels in elderly patients with different severity levels, with NLR increasing as severity increased (P < 0.001). The study identified cut-off values for preoperative NLR that could distinguish Simple cholecystitis and Purulent cholecystitis, as well as Purulent cholecystitis and Gangrenous cholecystitis in elderly patients with cholecystolithiasis, with respective AUCs of 0.8441 (95% CI: 0.7642-0.9239; P < 0.001) and 0.7886(95% CI: 0.7050-0.8721, P < 0.001), sensitivities of 91.38% and 87.72%, and specificities of 73.33% and 63.79%. Preoperative NLR and CRP values can serve as indicators to detect cholecystolithiasis with cholecystitis in elderly patients. Additionally, NLR has been recognized as a potential tool to differentiate the severity of cholecystolithiasis with cholecystitis in the elderly population.
Sections du résumé
BACKGROUND
BACKGROUND
This study aims to assess the effectiveness of neutrophil/lymphocyte ratio (NLR) and C-reactive protein (CRP) in diagnosing cholecystolithiasis with cholecystitis in elderly patients. Additionally, the study seeks to determine the predictive value of preoperative NLR in determining the severity of the condition in this population.
METHODS
METHODS
This study is a retrospective cohort study, including 160 elderly patients with cholecystolithiasis with cholecystitis (45 cases of simple cholecystitis, 58 cases of suppurative cholecystitis, 57 cases of gangrenous cholecystitis) and 60 cases of normal gallbladder histology. The study collected clinical data of the patients detected the preoperative CRP content, neutrophil, and lymphocyte levels through blood routine tests, and calculated the NLR value. The diagnostic value of NLR and CRP was determined by using the Receiver Operating Characteristic Curve (ROC), and the optimal value of preoperative NLR related to the severity of elderly patients with cholecystolithiasis with cholecystitis was identified.
RESULTS
RESULTS
This study found that for elderly patients with cholecystolithiasis with cholecystitis, preoperative NLR and CRP levels can be used to distinguish the condition. The critical value for NLR was found to be 2.995 (95% CI, 0.9465-0.9853; P < 0.001) with an area under the ROC curve of 0.9659, while the critical value for CRP was 13.05 (95% CI, 0.9284-0.9830; P < 0.001) with an area under the ROC curve of 0.9557. Both NLR and CRP were found to have equivalent diagnostic abilities. Additionally, the study found that there were significant differences in neutrophil and lymphocyte levels in elderly patients with different severity levels, with NLR increasing as severity increased (P < 0.001). The study identified cut-off values for preoperative NLR that could distinguish Simple cholecystitis and Purulent cholecystitis, as well as Purulent cholecystitis and Gangrenous cholecystitis in elderly patients with cholecystolithiasis, with respective AUCs of 0.8441 (95% CI: 0.7642-0.9239; P < 0.001) and 0.7886(95% CI: 0.7050-0.8721, P < 0.001), sensitivities of 91.38% and 87.72%, and specificities of 73.33% and 63.79%.
CONCLUSIONS
CONCLUSIONS
Preoperative NLR and CRP values can serve as indicators to detect cholecystolithiasis with cholecystitis in elderly patients. Additionally, NLR has been recognized as a potential tool to differentiate the severity of cholecystolithiasis with cholecystitis in the elderly population.
Identifiants
pubmed: 38012600
doi: 10.1186/s12893-023-02267-1
pii: 10.1186/s12893-023-02267-1
pmc: PMC10683304
doi:
Substances chimiques
C-Reactive Protein
9007-41-4
Biomarkers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
360Informations de copyright
© 2023. The Author(s).
Références
Medicine (Baltimore). 2018 Jun;97(25):e11200
pubmed: 29924043
Hepatogastroenterology. 2008 Nov-Dec;55(88):1975-80
pubmed: 19260462
Ann Ital Chir. 2022;93:550-556
pubmed: 36254774
Front Neurol. 2022 May 20;13:879882
pubmed: 35669880
Cells. 2023 Jun 29;12(13):
pubmed: 37443778
Aging Clin Exp Res. 2017 Jun;29(3):529-536
pubmed: 27216860
Eurasian J Med. 2022 Dec;54(Suppl1):66-70
pubmed: 36655448
J Hepatobiliary Pancreat Sci. 2022 Feb;29(2):212-216
pubmed: 33570821
Urolithiasis. 2022 Jun;50(3):341-348
pubmed: 35246692
Dig Liver Dis. 2023 Sep;55(9):1169-1177
pubmed: 36890051
BMC Res Notes. 2017 Jan 3;10(1):12
pubmed: 28057051
Am J Clin Pathol. 2020 Jan 1;153(1):14-29
pubmed: 31598629
Antibiotics (Basel). 2023 Feb 28;12(3):
pubmed: 36978349
Gastroenterology. 2023 Oct;165(4):e4-e5
pubmed: 36965741
Rev Esp Enferm Dig. 2021 Jan;113(1):41-44
pubmed: 33054305
Int J Clin Pract. 2021 Oct;75(10):e14664
pubmed: 34328252
Cureus. 2022 Feb 15;14(2):e22230
pubmed: 35340477
Int J Surg. 2017 Sep;45:1-7
pubmed: 28716660
Autoimmun Rev. 2023 Jan;22(1):103232
pubmed: 36414219
JAMA. 2022 Mar 8;327(10):965-975
pubmed: 35258527
Emerg Radiol. 2022 Feb;29(1):173-186
pubmed: 34787758
Front Immunol. 2018 Apr 13;9:754
pubmed: 29706967
Ann Rheum Dis. 2021 Dec;80(12):1604-1614
pubmed: 34663597
Brain Behav Immun. 2018 May;70:61-75
pubmed: 29499302
Int J Mol Sci. 2022 Mar 26;23(7):
pubmed: 35408994
J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):41-54
pubmed: 29032636
Ir J Med Sci. 2022 Apr;191(2):727-738
pubmed: 34021480
J Clin Ultrasound. 2016 Mar-Apr;44(3):152-8
pubmed: 26401961
Voen Med Zh. 1978 Oct;(10):39-41
pubmed: 706199
Emerg Radiol. 2021 Oct;28(5):1011-1027
pubmed: 34110530
Cureus. 2023 Mar 25;15(3):e36672
pubmed: 37123804
World J Emerg Surg. 2019 Mar 04;14:10
pubmed: 30867674
Ann Afr Med. 2019 Jul-Sep;18(3):121-126
pubmed: 31417011
Emerg Med Clin North Am. 1991 Nov;9(4):853-74
pubmed: 1915052
Clin Geriatr Med. 2021 Feb;37(1):43-69
pubmed: 33213774
Crit Rev Clin Lab Sci. 2020 Sep;57(6):389-399
pubmed: 32503382
Med Oncol. 2012 Dec;29(5):3092-100
pubmed: 22476808
Dig Endosc. 2023 Jul;35(5):668-669
pubmed: 36880174